The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LUNAR-2: Pivotal, randomized, open-label study of tumor treating fields (TTFields, 150 kHz) concomitant with pembrolizumab and platinum based chemotherapy for the treatment of metastatic non-small cell lung cancer.
 
Michael Scott-Soon Eaton
Travel, Accommodations, Expenses - Merck
 
Manuel Cobo
Consulting or Advisory Role - Novartis, AstraZeneca, Boehringer-Ingelheim, Roche, BMS, Lilly, MSD, Takeda, Phyzer, Kyowa, Sanofi,Jansen
Speakers' Bureau - Novartis, AstraZeneca, Boehringer-Ingelheim, Roche, BMS, Lilly, MSD, Takeda, Kyowa, Pierre-fabre, Novocure, Sanofi, Jansen
 
Li Zhang
Consulting or Advisory Role - AstraZeneca; Merck
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Hengrui Pharmaceutical (Inst); Kelun-Biotech Biopharm (Inst); Pfizer (Inst); QiLu Pharmaceutical (Inst); Roche (Inst); Sichuan Biokin Pharma (Inst); Zai Lab (Inst)
Travel, Accommodations, Expenses - Sichuan Biokin Pharm; Zai Lab
Other Relationship - AstraZeneca
 
Maximilian Hochmair
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Lilly; Roche; Takeda
Speakers' Bureau - Lilly; MSD Oncology; Novartis; Roche
 
Corey J. Langer
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Genentech/Roche; Gilead Sciences; GlaxoSmithKline; Merck; Mirati Therapeutics; Novocure; OncoCyteDX; Pfizer; Regeneron; Sanofi Aventis GmbH; Summit Therapeutics; Takeda; The radiation therapy oncology group foundation; Veterans Affairs
Research Funding - AstraZeneca; Fujifilm; Inovio Pharmaceuticals; Janssen; Lilly; Merck; Navire; OncoCyte; Takeda; Trizell